Clinical trial
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
NCT00004940 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00004940 |
|---|---|
| Title | Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Erythropoietic Protoporphyria |
| Intervention type | Drug |
| Interventions | cysteine hydrochloride |
| Enrollment | 50 |
| Start date | May 1, 1996 |
| Completion | Sep 1, 2001 |
| First posted | Feb 25, 2000 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: